rs2389591
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001101426.4(CRPPA):c.1251+26249T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.719 in 152,060 control chromosomes in the GnomAD database, including 39,703 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.72 ( 39703 hom., cov: 32)
Consequence
CRPPA
NM_001101426.4 intron
NM_001101426.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.782
Publications
4 publications found
Genes affected
CRPPA (HGNC:37276): (CDP-L-ribitol pyrophosphorylase A) This gene encodes a 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein. Mutations in this gene are the cause of Walker-Warburg syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2012]
CRPPA Gene-Disease associations (from GenCC):
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- myopathy caused by variation in CRPPAInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal recessive limb-girdle muscular dystrophy type 2UInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- congenital muscular dystrophy without intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.781 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CRPPA | NM_001101426.4 | c.1251+26249T>C | intron_variant | Intron 9 of 9 | ENST00000407010.7 | NP_001094896.1 | ||
| CRPPA | NM_001368197.1 | c.1146+26249T>C | intron_variant | Intron 8 of 8 | NP_001355126.1 | |||
| CRPPA | NM_001101417.4 | c.1101+26249T>C | intron_variant | Intron 8 of 8 | NP_001094887.1 | |||
| CRPPA | NR_160656.1 | n.1316+26249T>C | intron_variant | Intron 7 of 7 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CRPPA | ENST00000407010.7 | c.1251+26249T>C | intron_variant | Intron 9 of 9 | 5 | NM_001101426.4 | ENSP00000385478.2 | |||
| CRPPA | ENST00000399310.3 | c.1101+26249T>C | intron_variant | Intron 8 of 8 | 1 | ENSP00000382249.3 | ||||
| CRPPA | ENST00000676325.1 | c.948+26249T>C | intron_variant | Intron 10 of 10 | ENSP00000502074.1 | |||||
| CRPPA | ENST00000675257.1 | c.843+26249T>C | intron_variant | Intron 9 of 9 | ENSP00000501664.1 |
Frequencies
GnomAD3 genomes AF: 0.719 AC: 109207AN: 151942Hom.: 39655 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
109207
AN:
151942
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.719 AC: 109308AN: 152060Hom.: 39703 Cov.: 32 AF XY: 0.723 AC XY: 53754AN XY: 74318 show subpopulations
GnomAD4 genome
AF:
AC:
109308
AN:
152060
Hom.:
Cov.:
32
AF XY:
AC XY:
53754
AN XY:
74318
show subpopulations
African (AFR)
AF:
AC:
24925
AN:
41468
American (AMR)
AF:
AC:
12106
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
AC:
2935
AN:
3468
East Asian (EAS)
AF:
AC:
3856
AN:
5172
South Asian (SAS)
AF:
AC:
3611
AN:
4820
European-Finnish (FIN)
AF:
AC:
8231
AN:
10560
Middle Eastern (MID)
AF:
AC:
213
AN:
294
European-Non Finnish (NFE)
AF:
AC:
51138
AN:
67994
Other (OTH)
AF:
AC:
1551
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1526
3051
4577
6102
7628
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
836
1672
2508
3344
4180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2748
AN:
3474
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.